Michael D. Raleigh, Ph.D.
Affiliations: | 2013 | Pharmacology | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
PharmacologyGoogle:
"Michael Raleigh"Parents
Sign in to add mentor| Paul Pentel | grad student | 2013 | UMN | |
| (A heroin/morphine vaccine: Mechanism of action and extending its use to other abused opioids.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Song D, Crouse B, Vigliaturo J, et al. (2023) Multivalent Vaccination Strategies Protect against Exposure to Polydrug Opioid and Stimulant Mixtures in Mice and Rats. Acs Pharmacology & Translational Science. 7: 363-374 |
| Baehr C, Kassick AJ, Vigliaturo J, et al. (2023) Anti-Strychnine Immunoconjugate Reduces the Effects of Strychnine-Induced Toxicity in Mice. Acs Chemical Neuroscience |
| Hamid FA, Marker CL, Raleigh MD, et al. (2022) Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder. Vaccine. 40: 3244-3252 |
| Raleigh MD, Beltraminelli N, Fallot S, et al. (2021) Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodies. Plos One. 16: e0254247 |
| Raleigh MD, Accetturo C, Pravetoni M. (2020) Combining a candidate vaccine for opioid use disorders with extended-release naltrexone increases protection against oxycodone-induced behavioral effects and toxicity. The Journal of Pharmacology and Experimental Therapeutics |
| Raleigh MD, King SJ, Saykao AT, et al. (2020) Functional in vivo characteristics of antibodies generated by an oxycodone vaccine The Faseb Journal. 34: 1-1 |
| Baruffaldi F, Raleigh MD, King S, et al. (2019) Formulation and characterization of conjugate vaccines to reduce opioid use disorders suitable for pharmaceutical manufacturing and clinical evaluation. Molecular Pharmaceutics |
| Raleigh MD, Baruffaldi F, Peterson SJ, et al. (2018) Vaccination reduces fentanyl distribution to the brain and fentanyl-induced toxicity in mice and rats: a potential role for a prophylactic vaccine against fentanyl-induced overdose. The Journal of Pharmacology and Experimental Therapeutics |
| Pentel PR, Raleigh MD, LeSage MG, et al. (2018) The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats. Bmc Biotechnology. 18: 46 |
| Raleigh MD, Laudenbach M, Baruffaldi F, et al. (2018) Opioid dose- and route-dependent efficacy of oxycodone and heroin vaccines in rats. The Journal of Pharmacology and Experimental Therapeutics |